Camp4 Therapeutics (CAMP) Invested Capital (2023 - 2026)

Camp4 Therapeutics' Invested Capital history runs 4 years deep, the most recent figure standing at $30.9 million for Q1 2026.

• In Q1 2026, Invested Capital fell 40.2% year-over-year to $30.9 million; the TTM figure through Mar 2026 stood at $30.9 million (down 40.2% YoY), while the FY2025 annual figure was $47.7 million, down 24.64% from the prior year.
• Invested Capital came in at $30.9 million for Q1 2026 at Camp4 Therapeutics, down from $47.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $63.3 million in Q4 2024 to a low of -$159.0 million in Q3 2024.
• A 4-year average of -$34.9 million and a median of $30.9 million in 2026 frame the typical range for Invested Capital.
• On a YoY basis, Invested Capital climbed as much as 151.16% in 2024 and fell as far as 42.51% in 2024.
• Camp4 Therapeutics' Invested Capital stood at -$123.7 million in 2023, then surged by 151.16% to $63.3 million in 2024, then slipped by 24.64% to $47.7 million in 2025, then sank by 35.22% to $30.9 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $30.9 million, $47.7 million, and $58.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison